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ABSTRACT 
Introduction: The causes, prevalence and outcomes of renal disease in developing countries may 
differ compared to developed countries.  In most African countries, little data on the topic is 
available because of the lack of renal biopsy and chronic kidney disease (CKD)/end stage renal 
disease (ESRD) registries.  In view of the limited African data on the spectrum of renal disease, we 
have described the causes of biopsy-proven renal disease encountered at Tygerberg Hospital 
(TBH), in Cape Town, over a 23-year period and examined whether patterns have changed over 
this period. 
Methods: This retrospective study included all patients who underwent renal biopsies at TBH from 
January 1995 to December 2017.  Cases were identified from the records of the Division of 
Anatomical Pathology, where biopsy records are stored in paper files.  From these files, we 
created an electronic database using REDCap™, to digitize this archive. 
Results: This report is based on a total of 2564 native kidney biopsies, which were the first 
biopsies for each patient.  Slightly more biopsies were performed on females (53%).  The majority 
of the patients were between the ages of 20-39 (48.5%), while patients over 60 years and under 
20 years accounted for 6.6% and 13.3% respectively.  The most common indication for biopsy was 
nephrotic syndrome (42.4%).  Overall, the most common pattern of kidney disease observed was 
glomerulonephritis. Lupus nephritis (LN) was the most common glomerular disease (20.9%), 
followed by mesangiocapillary glomerulonephritis (MCGN, 16.4%), Focal segmental 
glomerulosclerosis (FSGS, 10.8%) and membranous nephropathy (MGN, 7.9%). The number of 
cases of primary and secondary glomerular diseases were similar. Among the primary glomerular 
disease, MCGN (32.2%) was the most common, followed by FSGS (21.2%), MGN (15.4%) and 
mesangioproliferative GN (14.5%). Among the secondary glomerular diseases, LN was the most 
common (42.4%), followed by Human immunodeficiency virus associated nephropathy (HIVAN, 
20.1%), diabetic nephropathy (DN, 13.7%) and Post infectious glomerulonephritis (PIGN, 13.3%).  
IgA nephropathy was uncommon, accounting for only 2.4% of all glomerular disease. The number 
of HIV-positive patients biopsied increased steadily over the study period, from only 2 in 1995 to 
40 patients in 2017.  Of the total of 519 HIV-positive patients, 44.1% had HIVAN. Of 218 patients 
identified as diabetics, diabetic nephropathy was identified in 68.3% and another renal disease 
was diagnosed in 32%.  Hypertensive renal disease was diagnosed in only 2.7% of all our biopsies.  
Myeloma kidney and amyloidosis were the most prevalent among the less common causes of 
renal disease, accounting for 1.5% and 1.1% of total biopsies, respectively.                 
Conclusion: An electronic renal registry was successfully established which will serve to facilitate 
good patient management and further research. Valuable new information has been generated 
regarding the patterns of renal disease in the Western Cape over the last two decades.  
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INTRODUCTION  
The global prevalence of chronic kidney disease (CKD) is estimated to be around 8-16%.1 The 
causes, prevalence and outcomes of renal disease in developing countries may differ compared to 
developed countries.  The major contributors of end stage renal disease (ESRD) in many developed 
countries are diabetes, hypertension and glomerulonephritis.2  Glomerular diseases are an 
important contributor to CKD worldwide.3  There is geographic and temporal variation in the 
spectrum of glomerular diseases reported, and this has been attributed to various demographic, 
economic and healthcare factors.3  In Europe, primary glomerular disease (disease confined to the 
kidney) is more common than secondary glomerular disease occurring as part of a multisystem 
disease. IgA nephropathy is the most common form of glomerular disease in Western Europe, 
Australia and some Asian countries, while focal segmental glomerulosclerosis (FSGS) is the most 
common form in South America.3     
In most African countries, little data on the topic is available because of the lack of renal biopsy 
and CKD/ESRD registries.  Where data is available, it suggests that the causes of ESRD are similar 
to those reported from developed countries, with hypertension, diabetic nephropathy and 
glomerular disease being the most common.4  The 2016 annual report of the South African Renal 
Registry lists the most commonly reported causes for ESRD as hypertensive renal disease, ESRD of 
unknown cause, diabetic nephropathy and glomerular disease (Table 1).5  Many of these common 
causes for ESRD presented late and diagnosis never confirmed histologically.       
Table 1. Most common reported causes of ESRD from the South African Renal Registry Annual 
Report 2016.  
 % of total 
Hypertensive renal disease 34.7 
Cause unknown 32.4 
Diabetic nephropathy 15.2 
Glomerular disease 9.9 
Cystic kidney disease 3.0 
Obstruction and reflux 1.7 
The total number of patients was 10257. 
Regarding glomerular disease in African countries, secondary glomerular diseases predominate 
and have been increasing in step with the human immunodeficiency virus (HIV) epidemic.  A 
systematic review of histologically-proven glomerulonephritis in Africa reported minimal change 
disease (MCD), FSGS and mesangiocapillary glomerulonephritis (MCGN) as the most common 
causes.6  Hepatitis B-related glomerulonephritis and lupus nephritis (LN) were the most common 
forms of secondary glomerular disease, with the former more prevalent in sub-Saharan Africa and 
the latter in North Africa.   This is not surprising considering the highest prevalence of hepatitis B 
virus (HBV) infection is in the sub-Saharan African region.6,17  A systemic review of worldwide 
prevalence of chronic hepatitis virus infection,17 published in 2015, found that many African 
countries have prevalence rates of greater than 8%. 
HIV is a major cause of renal disease in sub-Saharan Africa and it is estimated that less than half of 
affected individuals are receiving anti-retroviral therapy (ART).7,8  In South Africa it has an 
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estimated prevalence of 13.1%.9  The spectrum of kidney disease includes conditions directly 
associated with the virus, those linked to the systemic response to infection, complications of 
treatment,7 and coincidental renal disease such as diabetic nephropathy (DN) or LN occurring in an 
HIV positive patient.12   Classic HIV-associated nephropathy (HIVAN) is a collapsing form of FSGS 
with microcystic renal tubular dilatation, interstitial inflammation, fibrosis and tubulo-reticular 
inclusion bodies in endothelial cells.7  HIVAN accounted for only 1.0% of secondary glomerular 
diseases in an African systemic review by Okpechi et al., which may reflect under-reporting of this 
entity across Africa.6  In contrast, a study from Groote Schuur Hospital in Cape Town10 showed an 
increase in the frequency of HIVAN as a percentage of all biopsies, from 6.6% in 2000 to 25.7% in 
2009.  HIVAN was the main cause of secondary glomerular disease among younger black patients.   
In this study, classical HIVAN was also reported as the most common pattern of renal disease 
among HIV positive individuals.10 Similar results were reported from two other studies from 
Johannesburg, where HIVAN was the most commonly identified renal pathology.11,12  In the 
Vermeulen study from 2014,11 HIVAN was the second most common cause of secondary 
glomerular diseases, accounting for 13.3% (LN was the most common), and accounting for 6.5% of 
all biopsies.  In the Gerntholtz study,12 HIVAN accounted for 27.3% of total biopsies.    
In a study from Bloemfontein between 1997 and 2006,13 the majority of the patients included had 
CKD. Hypertension was presumed the likely underlying cause in most but only 2.8% were 
histologically proven.  Among those with renal histology, glomerular disease was the most 
common diagnosis, accounting for almost 20%, with FSGS being the most common pattern and IgA 
nephropathy the least.  
The Cape Town study10 reported MCGN as the most common primary glomerular disease.  Primary 
glomerular disease was more common among the elderly whereas secondary glomerular disease 
was more common among younger and middle-aged individuals.  LN was the most common 
secondary glomerular disease among patients of mixed ancestry (“Coloured”) and HIVAN the 
predominant cause among young Black patients.   
The Vermeulen study from Johannesburg, from 1982 to 2011, reported secondary glomerular 
disease as more prevalent than primary disease,11 and over the study period its frequency 
continued to rise, a finding also reported from Cape Town.  The main causes of secondary 
glomerular disease in the Johannesburg study were LN and HIVAN, and the main cause of primary 
glomerular disease was FSGS.11  
The other study from Johannesburg, from 2001 to 2010, showed a similar increasing frequency of 
secondary glomerular disease.  The most common primary glomerular disease was FSGS, followed 
by membranous nephropathy (membranous glomerulonephritis, MGN), while IgA nephropathy 
was relatively uncommon.  Among the secondary glomerular diseases, LN was by far the most 
common, accounting for more than half of cases, followed by DN and post-infective 
glomerulonephritis (PIGN).14 Table 2, below, summarizes the common patterns of glomerular 
disease in South Africa. 
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Table 2. Common patterns of glomerular disease in South Africa. 
Study Region Period Total biopsies PGN SGN 
Patchapen, 201714 
 
Johannesburg 2001-2010 1495 FSGS 29.8% 
MGN 19.5% 
MCGN 18% 
LN 55.8% 
Diabetic nephropathy 9.6% 
Vermeulen, 201411 
 
Johannesburg 1982-2011 1848 FSGS 29.6% 
MGN 25.7% 
MCGN 18.1% 
LN 31.0% 
HIVAN 13.3% 
van Rensburg, 200913 Bloemfontein 1997-2006 1216 FSGS 19.0% 
MCGN 14.9% 
MGN 11.5% 
LN 14.5% 
Okpechi, 201110 Cape Town 2000-2009 1753 MCGN 20.4% 
Mesangioproliferative GN 19.2% 
MGN 18.5% 
LN 39.0% 
Infection-related GN 30.1% 
FSGS, focal segmental glomerulosclerosis; MGN, membranous nephropathy; MCGN, mesangiocapillary GN; LN, lupus nephritis; HIVAN, HIV-
associated nephropathy.  PGN, primary glomerulonephritis; SGN, secondary glomerulonephritis. 
 
In view of the limited African data on the spectrum of renal disease, we have described the causes 
of biopsy-proven renal disease encountered at Tygerberg Hospital from 1995 to 2017, and 
examined whether patterns have changed over this period.  
 
METHODS 
Tygerberg Hospital (TBH) is a 1380-bed tertiary hospital in Cape Town, South Africa, which 
provides tertiary renal services to approximately 2.5 million people from the region.  The 
predominant ethnic group in South Africa is Black/Africans (80.8%) followed by people of mixed 
ancestry (“Coloured”, 8.8%)9.  In the Western Cape, however, people of mixed ancestry 
predominate, accounting for 48.8%, followed by Blacks (32.9%), Whites and Indian/Asians (Table 
3). 
Table 3. Ethnic distribution in South Africa and Western Cape9,16. 
Population group South Africa (%) Western Cape (%) 
Black 80.8 32.9 
Coloured  8.8 48.8 
White 8.0 15.7 
Indian/Asian 2.5 1.0 
 
We conducted a retrospective study that included all patients, adults and children, who 
underwent renal biopsies at TBH from January 1995 to December 2017.  Biopsies that were 
reviewed at Tygerberg Hospital but had been performed at other hospitals were excluded from 
the study.  
Renal biopsies are usually performed with patients in the prone position, targeting the lower pole 
of the left kidney. In the early part of the period described in the study, biopsies in patients with 
normal renal function were performed with the aid of radiocontrast screening, and in patients 
with raised creatinine levels they were done under ultrasound guidance. Conventional Tru-Cut 
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cutting needles were used initially, but recently the use of spring-loaded needles has been the 
norm, with all biopsies performed under direct, real-time ultrasound guidance. 
All renal tissue was evaluated by light microscopy, immunofluorescence and electron microscopy. 
Renal biopsy material was received fresh and unfixed, and evaluated and divided under a 
dissecting microscope to provide optimal numbers of glomeruli for light and electron microscopy 
as well as immunofluorescent studies. The ultrastructural material was then fixed in 2.5% 
glutaraldehyde in 0.1 M phosphate buffer, while the light microscopy material was fixed in 
buffered formalin. For light microscopy, serial two- to three-micron sections were stained with 
hematoxylin and eosin and other special stains as appropriate, including Congo Red. Material for 
immunofluorescence was frozen, cryostat sections cut and labeled for IgA, IgG, IgM and C3. 
Electron microscopy (EM) specimens were post-fixed in osmium tetroxide embedded in Spurr’s 
resin. 
All biopsies were reviewed at a weekly meeting which includes the nephrology team and the 
pathologist before a final diagnosis was made and the pathology report finalized. 
Cases were identified from the records of the Division of Anatomical Pathology, where biopsy 
records are stored in paper files.  These records consist of the renal histopathology request forms 
and the final pathology report. Request forms are completed by the nephrology team and contain 
key demographic and clinical information, as well as a provisional clinical diagnosis. From these 
files, we created an electronic database using REDCap15, a secure web application designed to 
support data capture for research, to digitize this archive. 
The measures implemented to improve data quality included the small dataset and the use of the 
REDCap system. REDCap facilitates easy and accurate data entry through the use of drop-down 
lists, radio buttons and checkboxes, and data validation. For example, date fields have a calendar 
control, and will only accept valid dates in the format year-month-day. Another example is the 
setting of a maximum valid values for albumin and haemoglobin concentrations. New users were 
trained on the REDCap system by Prof Davids using PDF versions of the online forms (Appendix 1) 
as well as the data dictionary (Appendix 2) as training materials. 
From the REDCap database, we extracted demographic and clinical information, including 
information on comorbidities, the clinical presentation and laboratory workup, as well as details of 
the renal biopsies including the final histopathological diagnosis. 
Descriptive statistics were used to summarize the patient demographics and biopsy data, including 
the indications for renal biopsy and the frequencies of each type of renal disease. Means and 
standard deviations were used to summarize normally distributed numerical data, and medians 
and interquartile ranges for nonparametric data. Frequencies and percentages were used to 
describe categorical data. 
Ethics approval, which included a waiver of individual informed consent, was obtained from the 
Stellenbosch University Health Research Ethics Committee (reference no.  N19/03/039).   
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RESULTS 
The total number of biopsies performed at Tygerberg Hospital (TBH) from January 1995 to 
December 2017 was 2888.  During this 23-year period, 2781 of the biopsies (96.3%) were reported 
by a single nephropathologist (WB).  The overwhelming majority were native biopsies (2684, 
92.9%), including 59 which were repeat or follow-up biopsies; and 61 biopsies that were either 
inconclusive due to inadequate tissue or normal histology.  There were 204 transplant biopsies, 
including 14 repeat biopsies.  Transplant rejection was the most common histopathological 
diagnosis in the transplant biopsies. The 2564 native kidney biopsies which were the first biopsies 
for each patient is the sample on which this report is based, see Figure 1. 
Figure 1. Study flow chart. 
 
 
 
 
 
 
 
 
 
 
 
Slightly more biopsies were performed on females (53%).  The age distribution of the patients is 
summarized in Table 4.  Biopsies in children (using the WHO definition of ≤19 years of age) 
accounted for 13.1% of all biopsies, and biopsies in children under 13 years of age accounted for 
3.9% of all biopsies. 
 
 
 
  
  
  
  
  
Total biopsies 
2888 
Native biopsies 
2684 
Transplant 
biopsies 204 
Repeat biopsies 
59 
First native biopsies 
2564 
Inadequate tissue 
sample 61 
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Table 4. Age distribution of patients undergoing renal biopsy at Tygerberg Hospital. 
Age (years) N % of total biopsies  
0-19  341 13.3 
20-39  1243 48.5 
40- 59  811 31.6 
>60  169 6.6 
Total 2564 100.0 
 
No data on ethnicity was available for the majority of patients (60.3%). Where ethnicity was 
recorded, mixed ancestry (“Coloured”) and Black patients were the predominant groups, 
comprising 17.6% and 16.6% of the total patients, respectively.  
We divided the 23 years of the study into 4 equal periods, each consisting of 69 months (5.75 
years).  Over time, the number of biopsies performed annually steadily increased (Figure 3), with 
almost twice as many biopsies performed over the last quartile (average 166 biopsies per annum) 
compared to the first (84 per annum). 
 
Figure 2. Number of renal biopsies performed per year, from 1995-2017. 
 
 
The most common indication for biopsy was nephrotic syndrome (42.4%) followed by unexplained 
acute kidney injury (AKI, 30.3%) and nephritic syndrome (20.4%).  These indications remained the 
most common throughout the study period.  Sub-nephrotic proteinuria and haematuria were the 
least common indications in all four quartiles; however, the number of biopsy for sub-nephrotic 
proteinuria increased by a small margin, accounting for 6.7% of all indications for biopsy in the 
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first quartile and 9.1% in the fourth quartile of the study.  Patients with isolated haematuria were 
seldom biopsied (median 1, range 0-4 per year).   
Figure 3. Indications for renal biopsy. 
 
 
Overall, the most common pattern of kidney disease observed was glomerulonephritis, followed 
by HIVAN, tubular necrosis, tubulointerstitial nephritis and diabetic nephropathy (DN).  
Hypertensive nephropathy was an uncommon diagnosis, accounting for around 1%. 
 
Table 5. Patterns of biopsy-proven kidney disease, in order of frequency. 
Pattern of kidney disease N % of all biopsies* 
Glomerulonephritis 1836 71.6 
HIVAN 230 9.0 
Tubular necrosis 174 6.8 
TIN 168 6.6  
Diabetic nephropathy 149 5.8 
ESRD 82 3.2 
Myeloma kidney 40 1.6 
Malignant hypertension  30 1.2 
Amyloidosis 28 1.1 
Thrombotic microangiopathy 15 0.6 
Other 36 1.4 
* Some patients had more than one histological diagnosis. 
Amongst the glomerular diseases, LN was the most common (20.9%).  This was followed by MCGN 
(16.4%), FSGS (10.8%) and MGN (7.9%).  We included DN and HIVAN among the secondary 
glomerular diseases.  The overall number of cases of primary and secondary glomerular diseases 
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were similar, 50.8% and 49.2%, respectively.  This trend was similarly observed throughout the 
study period, with exception to the third quartile where primary glomerular disease was slightly 
more prevalent.  
 
Figure 4. Proportion of primary and secondary glomerular disease over the 4 quartiles of the study 
period. 
 
 
Among the primary glomerular diseases, MCGN (32.3%) was the most common followed by FSGS 
(21.2%), MGN (15.4%) and mesangioproliferative GN (14.5%).   FSGS was the most common 
pattern in the first quartile, thereafter MCGN was consistently the most common pattern by a 
gradually increasing margin.   
 
Figure 5. Frequency of common primary glomerular diseases over the quartiles of the study 
period. 
 
MCGN, mesangiocapillary GN; FSGS, focal segmental glomerulosclerosis; MGN, membranous nephropathy. 
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Among the secondary glomerular diseases, LN was consistently the most common over the 23 
years (42.4%), followed by HIVAN (20.1%), DN (13.7%) and PIGN (13.3%).  From the second 
quartile, HIVAN was consistently the second most common of the secondary glomerular diseases.  
PIGN showed a steady decrease in frequency over the four quartiles of the study. 
 
Figure 6. Frequency of common secondary glomerular diseases over the quartiles of the study 
period.  
 
LN, lupus nephritis; HIVAN, HIV associated nephropathy; DN, diabetic nephropathy; PIGN, post infective glomerulonephritis 
 
The most common class of LN was class IV (55.0%), followed by class III (21.4%).  There were no 
cases of class I, and class VI (1.8%) was rarely reported.   
A total of 122 cases of crescentic glomerulonephritis were identified, with idiopathic 
glomerulonephritis diagnosed in the majority of these.  The most commonly identified underlying 
cause was MCGN, followed by pauci-immune glomerulonephritis.  All the cases of pauci-immune 
glomerulonephritis were positive for anti-neutrophil cytoplasmic antibody (ANCA). See Table 8. 
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Table 6. Causes of primary and secondary glomerular disease. 
Type N 
% of all 
glomerular 
disease 
(n=2215) 
% of primary 
glomerular 
disease 
(n=1126) 
% of secondary 
glomerular 
disease (n=1089) 
MCGN  364 16.4 32.3 - 
FSGS 239 10.8 21.2 - 
MGN 173 7.9 15.4 - 
Mesangioproliferative GN 163 7.4 14.5 - 
Idiopathic crescentic GN 68 3.1 6.0 - 
MCD 65 3.0 5.8 - 
IgA nephropathy 54 2.4 4.8 - 
LN 462 20.9 - 42.4 
HIVAN 230 10.4 - 20.1 
DN 149 6.7 - 13.7 
PIGN 144 6.5 - 13.2 
Pauci-immune GN 47 2.1 - 4.3 
Hepatitis B-related MCGN 29 1.3 - 2.7 
Hepatitis B-related MGN 14 0.6 - 1.3 
IE-related GN 7 0.3 - 0.6 
GBM disease 4 0.2  0.4 
RA related MGN 1 <0.1  <0.1 
Syphilis related MGN 1 <0.1  <0.1 
Syphilis related MCD 1 <0.1  <0.1 
* Note the inclusion of HIVAN and DN in this table.   MCGN, mesangiocapillary glomerulonephritis; MGN, membranous glomerulopathy; FSGS, focal 
segmental glomerulosclerosis; MCD, minimal change disease; PIGN, post-infectious glomerulonephritis; LN, lupus nephritis; DN, diabetic 
nephropathy; HIVAN, HIV-associated nephropathy; IE related GN, infective endocarditis-related glomerulonephritis; GBM, glomerular basement 
membrane disease; RA, rheumatoid arthritis. 
 
Table 7. Causes of crescentic glomerulonephritis. 
Underlying cause  N % of all crescentic 
glomerulonephritis 
Idiopathic crescentic GN 68 48.0 
MCGN 29 34.6 
Pauci-immune, ANCA+ GN 13 8.7 
LN (class IV) 4 3.1 
PIGN 4 2.4 
GBM disease 3 1.6 
MGN 1 0.8 
Total 122 100 
MCGN, mesangiocapillary glomerulonephritis; MGN, membranous glomerulopathy; FSGS, focal segmental glomerulosclerosis; PIGN, post infective 
glomerulonephritis; LN, lupus nephritis; GBM, glomerular basement membrane, ANCA-anti-neutrophil cytoplasmic antibody.  
 
IgA nephropathy was uncommon, accounting for only 2.4% of all glomerular disease.  It was 
predominantly diagnosed amongst Coloured individuals and was rare in Black patients. 
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Of the 2564 biopsies, 519 (20.2%) were from HIV-positive patients, and 44.1% had HIVAN. The 
number of HIV-positive patients biopsied increased steadily over the study period, from only 2 in 
1995 to 40 patients in 2017. This was mirrored by the increase in the cases of HIVAN.  Other renal 
diseases encountered among the HIV-positive patients included other glomerulonephritides, acute 
tubular necrosis, and TIN secondary ART or anti-tuberculosis drugs.  Among the 
glomerulonephritides, MCGN was the most common, followed by mesangioproliferative 
glomerulonephritis, FSGS and MGN.  In many patients more than one renal diagnosis was made. 
 
Table 8. Distribution of renal pathologies among HIV-positive patients undergoing renal biopsy. 
Renal pathology  N % of HIV patients (n=519) 
HIVAN 229 44.1 
Other glomerular diseases 
• Mesangioproliferative GN 
• PIGN 
• FSGS 
• MCGN 
• MGN 
• MCD 
• LN 
• Immune complex GN 
• IgA nephropathy 
• HIVICK 
• Glomerulosclerosis 
• Crescentic GN   
242 
40 
18 
26 
63 
25 
4 
12 
5 
2 
4 
19 
20 
46.6 
7.7 
3.5 
5.0 
12.1 
4.8 
0.8 
2.3 
1.0 
0.4 
0.8 
3.7 
3.9 
Tubular necrosis 202 38.9 
TIN 54 10.4 
Note that in many patients more than one renal disease was present. 
MCGN, mesangiocapillary glomerulonephritis; MGN, membranous nephropathy; FSGS, focal segmental glomerulosclerosis; MCD, minimal change 
disease; PIGN, post infective glomerulonephritis; LN, lupus nephritis; TIN, tubulointerstitial nephritis; HIVAN, HIV associated nephropathy; HIVICK, 
HIV immune complex kidney disease. 
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Figure 7. Frequency of HIVAN among HIV-positive patients undergoing renal biopsy. 
      
 
Hepatitis B was more common than hepatitis C seropositivity, and was documented for 97 and 9 
patients, respectively. Hepatitis B was predominantly associated with MGN (14 cases) and MCGN 
(29 cases), accounting for 7.5% of all MGN and 7.8% of all MCGN.  In the 9 patients with hepatitis 
C, one had MCGN, the other had idiopathic crescentic GN, and one had ESRD of unknown cause.  
In the remaining 6 cases, the renal pathology was attributed to another obvious condition, such as 
diabetes or SLE. 
A total of 218 patients were identified as diabetics, mostly type 2 (83.5%). Among them, 68.3% 
had diabetic nephropathy, 32% had a renal disease other than diabetic nephropathy and 20% had 
a combination, as shown in Figure 8.  The number and proportion of diabetic patients having renal 
biopsies steadily increased over the four quartiles from 4.6% in the first quartile, to 9.7% in the 
third and 10.1% in the fourth. 
0
10
20
30
40
50
60
70
Number of patients
Year
Other renal disease
HIVAN
Stellenbosch University  https://scholar.sun.ac.za
20 
 
Figure 8. Renal diseases among diabetics. 
 
   
Table 9. Renal diseases among diabetics. 
 N % of total diabetics (218) 
Diabetic nephropathy 149 68.3 
Glomerular disease* 
• MCGN 
• FSGS 
• Glomerulosclerosis 
88 
23 
18 
12 
40.4 
10.6 
8.3 
5.5 
Tubulo-interstitial nephritis 17 7.8 
Tubular necrosis 9 4.1 
* Only the three most common causes of glomerular disease in diabetic patients are listed. MCGN, 
mesangiocapillary glomerulonephritis; FSGS, focal segmental glomerulosclerosis. 
 
Hypertension was documented in almost half of the patients (48.2%); however, hypertensive renal 
disease was diagnosed in only 37 patients (2.7%). 
Myeloma kidney and amyloidosis were the most prevalent among the less common and rare 
causes of renal disease, accounting for 1.6% and 1.1% of total biopsies, respectively.  Other causes 
included malignancies other than myeloma, infective endocarditis-related glomerulonephritis, 
haemolytic-uraemic syndrome (HUS) and thrombotic thrombocytopenic purpura (TTP). 
 
 
 
 
 
48%
32%
20%
Renal disease among diabetics
Diabetic nephropathy
Renal disease other than diabetic nephropathy
Combination of diabetic nephropathy and other renal disease
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Table 10. Uncommon diseases diagnosed on kidney biopsy.  
 
HUS/TTP- haemolytic-uraemic syndrome/thrombotic thrombocytopenic purpura. 
 
DISCUSSION 
The most common indication for renal biopsy in Tygerberg Hospital over the study period was 
nephrotic syndrome, in line with other South African and international studies.  The least common 
indication was microscopic haematuria and asymptomatic urine abnormalities such as the 
presence of an active urine sediment.  This is in contrast to international reports, particularly from 
Europe and North America.3  
 
Glomerulonephritis was the most commonly diagnosed renal disease on renal biopsy.   The 
distribution of primary and secondary glomerular diseases was almost equal.  Among the primary 
glomerular diseases, MCGN was the most common, similar to the findings of another study 
conducted in Cape Town10 and in contrast to the reports from Bloemfontein and Johannesburg, 
where FSGS was predominant.11,13 The reasons for this geographical variation are not clear. 
Among the factors that may be relevant is the different ethnic distribution of the population in the 
Western Cape, where persons of mixed ancestry make up the largest group. Another factor is the 
increasing use of crystal meth, the primary illicit drug used in the Western Cape.19 At Groote 
Schuur Hospital, Cape Town, Jones et al.27 reported that renal biopsies in patients with a history of 
methamphetamine use revealed MCGN in 58.3%, suggesting an association.  Anecdotally, and in 
common with the findings of the Groote Schuur group, 28 we have also noted MCGN to be a 
common renal diagnosis in individuals who have been incarcerated, and also speculate that it may 
be related to exposure to drugs, infections or tattoo ink in prison.   
IgA nephropathy was the least common glomerular disease, as reported by other South African 
and African studies, but quite different from the findings in Europe, where it is the most common.3 
This could possibly be explained by the low number of biopsies performed on patients with 
Diseases N 
% of all biopsies 
(n=2564) 
Myeloma kidney 40 1.6 
Amyloidosis  28 1.1 
HUS/TTP 10 0.4 
Granulomatous interstitial nephritis 8 0.3 
Infective endocarditis-related GN 7 0.3 
Pyelonephritis  7 0.3 
Goodpasture’s disease  4 0.2 
Scleroderma renal crisis 4 0.2 
Malignancy other than myeloma 3 0.1 
Dense deposit disease 2 <0.1 
Cholesterol emboli  1 <0.1 
Alport syndrome 1 <0.1 
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isolated hematuria.  Among the secondary glomerular diseases, LN was the most common, as it 
was in most other South African studies.  Despite no clear data regarding the prevalence of SLE in 
Africa and South Africa, the Western Cape is considered to have a high prevalence of systemic 
lupus erythematosis (SLE).  Renal complication is a common manifestation of SLE and also 
associated with a poorer prognosis.18,25,26  Up to 50% of SLE patients have abnormalities in renal 
function or urine, and up to 80% will develop abnormalities at some point during the course of the 
disease.25 Class IV lupus nephritis was the predominant histological pattern, followed by class III.  
Similar results were obtained from another study conducted at Tygerberg Hospital which included 
LN cases diagnosed between 1983 and 2012.  In that study, class IV was also the most common, 
followed by class III and no cases of class I or VI were reported.18    These proliferative forms of LN 
were also found to be more common and associated with worst prognosis in other Cape Town 
studies.18,25          
 
The number of HIV-positive patients having renal biopsies increased sharply over the period of the 
study.  This was in keeping with data from Statistics South Africa which clearly shows an increase 
in the total number of HIV patients over the last 20 years.9 HIVAN was the most commonly 
identified pathology and was the second most common secondary glomerular disease reported in 
our study.  HIV-associated immune complex disease was uncommon.  It is interesting that the 
number of HIV-positive patients having biopsies, and consequently the diagnosis of HIVAN, 
dropped off after 2013.  This could potentially be explained by increases in HIV awareness and use 
of ART and therefore less renal complications.  The UNAIDS target for 2020 is to achieve a 90% 
rate of diagnosis in HIV positive individuals, and South Africa is well on its way to achieving those 
targets.24 There has been a more than two-fold increase in the number of people on ART from 
2010 to 2015 in South Africa, as well as in the Western Cape.24   
Certain variants of the APOL1 gene which are common among Africans confer increased risk of 
CKD.7 HIVAN, primary FSGS, and other non-diabetic renal disease are related to the “risk” alleles.7  
A study from Johannesburg has reported an association between lupus nephritis and APOL1 risk 
alleles in black South Africans.20            
Diabetic nephropathy accounted for 13.7% of all secondary glomerular disease, making it the third 
most common after LN and HIVAN.  According to the South African Renal Registry, diabetes is the 
cause of ESRD in 15.2% of South Africans on RRT.  Renal disease other than diabetic nephropathy 
were diagnosed in 32% of the diabetics in our study. In another study conducted at Tygerberg 
Hospital, 22 non-diabetic renal disease was found in 45% of diabetics who were biopsied between 
2003 and 2012. These findings highlight the importance of performing renal biopsies in diabetic 
patients who have renal disease and a clinical picture which is not typical of diabetic 
nephropathy.23         
Hypertensive renal disease is one of the most common reported causes of ESRD worldwide; 
however, in many cases the diagnosis is presumed and not proven histologically.  In our study 
hypertensive renal disease was diagnosed in only 2.7% of all our biopsies despite approximately 
half of our patients being hypertensive. This finding is similar to that of the Bloemfontein study, 
where CKD in the majority of the patients was thought to be related to hypertension but only 2.8% 
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were proven histologically.  It is generally agreed that malignant hypertension can lead to 
irreversible kidney failure; however, the role of mild-to-moderate hypertension as a cause of ESRD 
remains debatable.21 Certain genetic variants, such as the APOL1 variants, may cause glomerular 
disease (often with FSGS) and secondary hypertension. Many cases of CKD in patients with mild-
to-moderate systemic hypertension may be misclassified as being due to “hypertension-attributed 
nephropathy” whereas it may be due to primary glomerular disease.21  
Regarding the strengths and limitations of our study, most of the renal biopsies (greater than 90%) 
were reported by a single nephropathologist, ensuring a high level of consistency in the reporting.  
Some of the limitations involved missing data, for example, data on ethnicity and serological tests.   
 
Conclusions 
This study served two main purposes, to provide information regarding patterns of renal disease in 
the Western Cape over the last two decades, as well as to create an electronic renal database for 
good patient management and from which further studies will be performed more readily.  
Nephrotic syndrome was the most common indication for renal biopsy and glomerulonephritis 
was the most common pattern of renal disease reported. MCGN was the most common primary 
glomerular disease and LN the most common secondary glomerular disease. IgA nephropathy was 
rare. We noticed a significant increase in the number of HIV-positive patients having biopsies over 
the course of the 23 years, which correlated with increases in the cases of HIVAN.  Almost one-
third of the diabetic patients who were biopsied had a renal disease other than diabetic 
nephropathy.  Hypertensive nephropathy was an uncommon histological diagnosis.  
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